Navigation Links
Spectral appoints two new board members
Date:3/10/2010

TORONTO, March 10 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI), a company developing products for the treatment of sepsis, today announced the appointment of Mr. Kevin Giese, President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC, Senior Legal Counsel of TEC Edmonton, to the Company's Board of Directors.

"Mr. Giese and Mr. Woollard will be valuable additions to the Board, bringing significant business experience," said Dr. Paul Walker, President and CEO of Spectral. "Their leadership will be important to Spectral as the Company implements its theranostics strategy in the area of sepsis."

Mr. Giese has a B.A. in economics, a law degree, and an M.B.A. He is the founding President of BioMS Medical, and has been in senior management roles and on the board of directors of a number of private and publicly listed companies. He is a past advisory board member of the Institute of Corporate Directors (Canada) and is currently a member of the Board of Directors of BioAlberta. In 2005, he received the BioAlberta Award for Entrepreneurship.

Mr. Woollard has degrees in Pharmacy and Pharmaceu
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
2. Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin(TM)
3. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
4. First Spaceborne Hyperspectral Imager Will Use QImaging Rolera-MGi EMCCD Camera
5. Spectral appoints new board member
6. Spectral announces second quarter 2009 results
7. Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial
8. Spectral announces first quarter 2009 results
9. Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin
10. Spectral announces 2008 financial results
11. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014  WIRB-Copernicus Group (WCG), the ... services for clinical research, announced today that its ... been reaccredited by the Association for the Accreditation ... to improve safeguards for clinical research participants. ... Deieso , Ph.D., commented, "It is of utmost ...
(Date:9/22/2014)... Mass. , Sept. 22, 2014 ... GEVA ), a biopharmaceutical company developing therapeutic ... of Robert Bazemore as Chief Operating ... , President and Chief Executive Officer, Robert will ... company,s lead program, sebelipase alfa for LAL Deficiency, ...
(Date:9/21/2014)... to produce ultra-thin "diamond nanothreads" that promise extraordinary properties, ... strongest nanotubes and polymers. A paper describing this discovery ... a professor of chemistry at Penn State University, will ... the journal Nature Materials . , "From a ... the threads we formed have a structure that has ...
(Date:9/20/2014)... HealthTronics, Inc. , a leading ... and services, has signed a distribution agreement through ... for its high precision laser technology. ... mobile, surgical technology—offering more choices for healthcare providers ... will make available Clinicon’s FDA-cleared SureLase™ CO2 Laser ...
Breaking Biology Technology:Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3
... facility provides patients access to advanced gene-sequencing,technologies and ... SEATTLE, Oct. 16 Swedish Neuroscience,Institute (SNI) ... Center,s,newly renovated Cherry Hill Campus, the Center for ... its doors to patients diagnosed,with both benign and ...
... (AATI), based in Ames, IA will expand its office ... to current operations. The expansion,adjoins the current office space ... Park campus. Although the 35 person, 10 year old ... building on the,Research Park Campus, the expansion will make ...
... Promising Patient Solutions, MARQUETTE, Mich., Oct. ... in innovative medical devices, announced today the,successful ... spacer. The,nanOss(TM)- Cervical cage is machined from ... to function as bone.,The surgeries were performed ...
Cached Biology Technology:Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research 2Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research 3Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research 4Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space 2Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device 2
(Date:9/21/2014)... main contributor to global warming, are set to rise again ... tonnes. , The 2.5 per cent projected rise in burning ... is co-led in the UK by researchers at the Tyndall ... Anglia and the College of Engineering, Mathematics and Physical Sciences ... the New York Climate Summit, where world leaders will seek ...
(Date:9/21/2014)... what was previously thought, newborn immune T cells may ... bacteria, according to a new study led by King,s ... to that of adults, babies may still be able ... published in the journal Nature Medicine . , ... types of immune cells, including neutrophils which play an ...
(Date:9/19/2014)... Call it the Jimmy Durante of dinosaurs ... nasal profile. The new dinosaur, named Rhinorex ... University and Brigham Young University, lived in what ... during the Late Cretaceous period. , Rhinorex, which ... and a close relative of other Cretaceous hadrosaurs ...
Breaking Biology News(10 mins):CO2 emissions set to reach new 40 billion ton record high in 2014 2CO2 emissions set to reach new 40 billion ton record high in 2014 3Immune system of newborn babies is stronger than previously thought 2New hadrosaur noses into spotlight 2
... World leaders have made pitiful progress on their guarantee to ... a paper published today (Friday 15th June) in Science ... researchers have reviewed commitments made by governments to protect the ... over the past 20 years. At the World ...
... found a surprising connection between a key DNA-repair process and ... and other chronic conditions. The discovery promises to open up ... could ultimately yield novel treatments for a wide variety of ... it goes against current dogma about the role of DNA ...
... the Instituto Andaluz de Ciencias de la Tierra and other ... published in the prestigious journal Reviews of Modern Physics ... different countries has published the most comprehensive study ever done ... important contemporary issues in a field of research that is ...
Cached Biology News:A sea of broken promises 2Scientists tie DNA repair to key cell signaling network 2Spanish scientist participate in the most comprehensive study ever done on ice 2
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Biology Products: